AMRX
Price
$7.19
Change
-$0.08 (-1.10%)
Updated
May 22 closing price
Capitalization
1.87B
76 days until earnings call
PBH
Price
$84.42
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
3.6B
69 days until earnings call
Interact to see
Advertisement

AMRX vs PBH

Header iconAMRX vs PBH Comparison
Open Charts AMRX vs PBHBanner chart's image
Amneal Pharmaceuticals
Price$7.19
Change-$0.08 (-1.10%)
Volume$1.56M
Capitalization1.87B
Prestige Consumer Healthcare
Price$84.42
Change-$0.00 (-0.00%)
Volume$443.42K
Capitalization3.6B
AMRX vs PBH Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. PBH commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and PBH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (AMRX: $7.19 vs. PBH: $84.42)
Brand notoriety: AMRX and PBH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 79% vs. PBH: 112%
Market capitalization -- AMRX: $1.87B vs. PBH: $3.6B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. PBH’s [@Pharmaceuticals: Other] market capitalization is $3.6B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 2 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 2 green, 3 red.
According to our system of comparison, PBH is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 2 TA indicator(s) are bullish while PBH’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 2 bullish, 6 bearish.
  • PBH’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PBH is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -4.13% price change this week, while PBH (@Pharmaceuticals: Other) price change was -3.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.08%. For the same industry, the average monthly price growth was +10.49%, and the average quarterly price growth was +31.12%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

PBH is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.08% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.6B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than PBH: AMRX (90.00) vs PBH (14.90). PBH YTD gains are higher at: 8.106 vs. AMRX (-9.217). AMRX has higher annual earnings (EBITDA): 400M vs. PBH (10.8M). AMRX has more cash in the bank: 91.5M vs. PBH (63.6M). PBH has less debt than AMRX: PBH (1.21B) vs AMRX (2.75B). AMRX has higher revenues than PBH: AMRX (2.39B) vs PBH (1.13B).
AMRXPBHAMRX / PBH
Capitalization1.87B3.6B52%
EBITDA400M10.8M3,704%
Gain YTD-9.2178.106-114%
P/E Ratio90.0014.90604%
Revenue2.39B1.13B211%
Total Cash91.5M63.6M144%
Total Debt2.75B1.21B227%
FUNDAMENTALS RATINGS
AMRX vs PBH: Fundamental Ratings
AMRX
PBH
OUTLOOK RATING
1..100
7111
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
567
SMR RATING
1..100
9660
PRICE GROWTH RATING
1..100
5848
P/E GROWTH RATING
1..100
2321
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBH's Valuation (83) in the Pharmaceuticals Other industry is in the same range as AMRX (92) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to AMRX’s over the last 12 months.

PBH's Profit vs Risk Rating (7) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (56) in the Pharmaceuticals Major industry. This means that PBH’s stock grew somewhat faster than AMRX’s over the last 12 months.

PBH's SMR Rating (60) in the Pharmaceuticals Other industry is somewhat better than the same rating for AMRX (96) in the Pharmaceuticals Major industry. This means that PBH’s stock grew somewhat faster than AMRX’s over the last 12 months.

PBH's Price Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as AMRX (58) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to AMRX’s over the last 12 months.

PBH's P/E Growth Rating (21) in the Pharmaceuticals Other industry is in the same range as AMRX (23) in the Pharmaceuticals Major industry. This means that PBH’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPBH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
54%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
54%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
59%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 3 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ASMNX18.380.03
+0.16%
AQR Small Cap Momentum Style N
BALFX34.870.03
+0.09%
American Funds American Balanced F1
GCSCX17.97N/A
N/A
Goldman Sachs Small Cap Eq Insghts C
MSHLX46.61N/A
N/A
Morgan Stanley Inst Growth L
GGHSX37.17N/A
N/A
Invesco Health Care R6

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-1.10%
PAHC - AMRX
44%
Loosely correlated
N/A
HROW - AMRX
41%
Loosely correlated
N/A
VTRS - AMRX
38%
Loosely correlated
+0.24%
TEVA - AMRX
38%
Loosely correlated
N/A
ZTS - AMRX
38%
Loosely correlated
+0.33%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
N/A
PAHC - PBH
48%
Loosely correlated
N/A
VTRS - PBH
38%
Loosely correlated
+0.24%
AMRX - PBH
32%
Poorly correlated
-1.10%
ZTS - PBH
32%
Poorly correlated
+0.33%
IRWD - PBH
32%
Poorly correlated
+5.28%
More